Work

Pilot Randomized Trial Comparing the Effects of Alemtuzumab and Cyclosporine Versus Tacrolimus, Methotrexate and Sirolimus on Graft Versus Host Disease Prevention, Engraftment and Immune Reconstitution After Reduced Intensity Unrelated Donor Transplantation.

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.1245.1245

Authors: Rachel B. Salit, Steven Z. Pavletic, Daniel H. Fowler, Jennifer Wilder, Kelly Bryant, Seth M. Steinberg, Frances T. Hakim, Michael R. Bishop

Institutions: National Cancer Institute, National Institutes of Health, Science Applications International Corporation (United States)

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2576796461

FWCI: 0.359

Cites:

Cited by: 2

Related to: 10